Gene rearrangements of Mixed Lineage Leukemia (MLL; also known as KMT2A) gene account for 7 and 6% of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) cases, respectively2. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.